The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes and molecular characteristics of patients with metastatic pancreatic ductal adenocarcinoma according to involved metastatic sites.
 
Mahmoud Yousef
No Relationships to Disclose
 
Sali Albarouki
No Relationships to Disclose
 
Ahmed Elhariri
No Relationships to Disclose
 
Guglielmo Vetere
No Relationships to Disclose
 
Mohammad Mahdi Fanaeian
No Relationships to Disclose
 
Mark Hurd
No Relationships to Disclose
 
Paul Roy
No Relationships to Disclose
 
Kristin Alfaro
Consulting or Advisory Role - Abbvie; SDP Oncology
 
Abdelrahman Yousef
Other Relationship - Palantir Technologies
 
Brandon Smaglo
Consulting or Advisory Role - Ipsen; Syros Pharmaceuticals
Research Funding - AstraZeneca; Merck
(OPTIONAL) Uncompensated Relationships - Ipsen
 
Robert Wolff
Honoraria - Conveners
Patents, Royalties, Other Intellectual Property - Royalties from McGraw-Hill: Editor: M.D. Anderson Manual of Medical Oncology, 3rd edition.
 
Matthew Katz
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Alcresta Therapeutics; Nestle health science; Taiho Oncology
Travel, Accommodations, Expenses - Intuitive Surgical
 
Rebecca Snyder
No Relationships to Disclose
 
Shubham Pant
Stock and Other Ownership Interests - Teleprian
Consulting or Advisory Role - Alligator Bioscience; Arcus Biosciences; AskGene Pharma; AstraZeneca; Boehringer Ingelheim; BPGbio; Ipsen; Janssen; Jazz Pharmaceuticals; Merck; Nihon Medi-Physics; Novartis; Pfizer; Revolution Medicines; US WorldMeds
Research Funding - 4D Pharma (Inst); Amal Therapeutics (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); bionte (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Immuneering (Inst); ImmunoMET (Inst); Ipsen (Inst); Janssen (Inst); Lilly (Inst); Mirati Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Novartis (Inst); Pfizer (Inst); Purple Biotech (Inst); Rgenix (Inst); Xencor (Inst); Zymeworks (Inst)
 
Jason Willis
Honoraria - Bayer; Cor2Ed
Consulting or Advisory Role - Healios, K.K.
 
Ryan Huey
Honoraria - Aptitude Health; Clinical Care Targeted Communications LLC; Vizient
Travel, Accommodations, Expenses - Clinical Care Targeted Communications LLC; Vizient
 
Michael Overman
Consulting or Advisory Role - 3T BioSciences; Agenus; Bristol-Myers Squibb; Eisai; Janssen; Merck; Pfizer; Roche/Genentech; Simcere; Summit Therapeutics
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Ethan Ludmir
Employment - Alaunos Therapeutics (I)
Honoraria - Nanobiotix
Consulting or Advisory Role - Xerient
 
John Paul Shen
Stock and Other Ownership Interests - Agios; Syndax; Syndax
Consulting or Advisory Role - Engine Biosciences; NaDeNo Nanosciences
Research Funding - BostonGene; Ikena Oncology (Inst)
 
Dan Zhao
Consulting or Advisory Role - Affinit-T; Ipsen
Research Funding - CARsgen Therapeutics (Inst); Mirati Therapeutics (Inst); TriSalus Life Sciences (Inst)